1. Home
  2. MMED vs IRTC Comparison

MMED vs IRTC Comparison

Compare MMED & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$16.72

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$109.13

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMED
IRTC
Founded
1983
2006
Country
United States
United States
Employees
2800
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.7B
IPO Year
2026
2016

Fundamental Metrics

Financial Performance
Metric
MMED
IRTC
Price
$16.72
$109.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
13
Target Price
$22.56
$197.92
AVG Volume (30 Days)
1.1M
620.1K
Earning Date
06-03-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
N/A
$747,138,000.00
Revenue This Year
$15.99
$19.60
Revenue Next Year
$10.00
$15.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.24
52 Week Low
$10.65
$100.85
52 Week High
$17.86
$210.01

Technical Indicators

Market Signals
Indicator
MMED
IRTC
Relative Strength Index (RSI) 66.74 41.01
Support Level $14.70 $101.30
Resistance Level N/A $121.88
Average True Range (ATR) 0.85 5.51
MACD 0.12 -1.32
Stochastic Oscillator 78.65 4.54

Price Performance

Historical Comparison
MMED
IRTC

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: